Evidence map›Paper›PMID 38204275›Full record

ArticleCurrent drug safety2024

Treatment Modalities for Trigeminal Neuralgia and the Need for Vigilance in Monitoring Adverse Drug Events: A Case Report.

Raja Narendra Divakar Addanki, Anjali Srikanth Mannava, Hemasri Velmurugan, Pugazhenthan Thangaraju

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Current drug safety, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Raja Narendra Divakar AddankiDepartment of Pharmacology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
Anjali Srikanth MannavaDepartment of Pharmacology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
Hemasri VelmuruganDepartment of Pharmacology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.ORCID 0000-0002-1388-957X
Pugazhenthan ThangarajuDepartment of Pharmacology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.ORCID 0000-0002-4090-2004

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTrigeminal neuralgia is a rare condition characterised by paroxysms of intense pain in the distribution of the trigeminal nerve. This condition significantly diminishes the patient's quality of life, and the side effects from chronic use of medications for symptomatic relief further exacerbate their distress. CASE DESCRIPTION: The case report discusses a patient diagnosed with Trigeminal Neuralgia who commenced carbamazepine treatment. The report tracks the disease's progression, medication adjustments, and the eventual emergence of vertigo due to long-term carbamazepine use.

conclusionThe article covers fundamental information about trigeminal neuralgia and its management and also offers a comprehensive review of the basics of vertigo. It delves into carbamazepine's mechanism of action and its associated side effects. The paper also looks at prospective therapy changes that could improve patients' quality of life.

Indexed as

CarbamazepineTrigeminal NeuralgiaAnalgesics, Non-NarcoticFemaleHumansMaleMiddle AgedQuality of LifeVertigoAnalgesics, Non-NarcoticCarbamazepinecarbamazepinediagnosispatient care managementpregabalin.trigeminal neuralgiavertigo

Identifiers

PMID38204275

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.